Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
3.500
-0.250 (-6.67%)
At close: Nov 13, 2026, 4:00 PM EST
3.430
-0.070 (-2.00%)
After-hours: Nov 13, 2026, 5:28 PM EST

Starling Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-35.54-60.61-64.66-83.070.15-10.93
Depreciation & Amortization
6.616.946.295.874.413.34
Other Amortization
6.78.386.316.212.440.05
Loss (Gain) From Sale of Assets
0.15-0.27-0.030.02-
Asset Writedown & Restructuring Costs
-2.4-16.879.94-
Loss (Gain) From Sale of Investments
---0.63-2.88-0.64-
Stock-Based Compensation
5.424.5511.1517.8127.6824.54
Provision & Write-off of Bad Debts
0.2--2.020.48-0.42
Other Operating Activities
5.712.42-3.32-1.47-85.7-34.78
Change in Accounts Receivable
-1.24-12.31-5.98-4.56-20.29-2.2
Change in Inventory
-17.75-6.843.64-4.39-1.73-1.84
Change in Accounts Payable
46.9619.649.225.06-6.192.92
Change in Income Taxes
----0.260.12-1.01
Change in Other Net Operating Assets
5.890.8311.186.517.54-12.36
Operating Cash Flow
23.1-24.59-26.54-36.32-61.76-32.68
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.27-3.2-3.79-4.57-5.53-2.85
Sale of Property, Plant & Equipment
-0.13----
Cash Acquisitions
----4.46-8.58-9.11
Sale (Purchase) of Intangibles
------0.2
Investment in Securities
--5071.66-117.51-
Investing Cash Flow
-4.27-3.0746.2162.64-131.61-12.15

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----1108.43
Long-Term Debt Repaid
--21.03-1.2-3.37-5.07-7.66
Net Debt Issued (Repaid)
-7.01-21.03-1.2-3.37104.930.77
Issuance of Common Stock
6.3832.640.080.130.86-
Repurchase of Common Stock
----1.02-9.41-
Other Financing Activities
-8.97-0.05-2.37-2.58-4.17133.24
Financing Cash Flow
-9.5911.56-3.49-6.8592.21154.01

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
9.24-16.116.1819.48-101.16109.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
18.83-27.79-30.33-40.88-67.29-35.53
Free Cash Flow Growth
------
Free Cash Flow Margin
3.03%-5.53%-7.71%-12.61%-26.65%-17.50%
Free Cash Flow Per Share
0.18-0.30-0.40-0.55-0.83-0.54
Levered Free Cash Flow
29.5-11.03-8.19-16.33-40.79-13.34
Unlevered Free Cash Flow
29.3-12.36-9.81-18.3-40.69-13.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.453.914.54.510.220.28
Cash Income Tax Paid
---0.40.151.73
Change in Working Capital
33.861.3318.062.36-20.54-14.49
SEC Filings: 10-K · 10-Q